Erythroid lineage-restricted expression of Jak2V617F is sufficient to induce a myeloproliferative disease in mice

Por Akada, Hajime, Akada, Saeko, Hutchison, Robert E., Mohi, Golam
Publicado em 2012

Loss of wild-type Jak2 allele enhances myeloid cell expansion and accelerates myelofibrosis in Jak2V617F knock-in mice

Por Akada, Hajime, Akada, Saeko, Hutchison, Robert E., Mohi, Golam
Publicado em 2014

Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm

Por Yang, Yue, Akada, Hajime, Nath, Dipmoy, Hutchison, Robert E., Mohi, Golam
Publicado no Blood (2016)

Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera–like disease

Por Akada, Hajime, Yan, Dongqing, Zou, Haiying, Fiering, Steven, Hutchison, Robert E., Mohi, M. Golam
Publicado em 2010

Critical Role of Jak2 in the Maintenance and Function of Adult Hematopoietic Stem Cells

Por AKADA, HAJIME, AKADA, SAEKO, HUTCHISON, ROBERT E., SAKAMOTO, KAZUHITO, WAGNER, KAY-UWE, MOHI, GOLAM
Publicado em 2014

Efficacy of vorinostat in a murine model of polycythemia vera

Por Akada, Hajime, Akada, Saeko, Gajra, Ajeet, Bair, Alicia, Graziano, Stephen, Hutchison, Robert E., Mohi, Golam
Publicado em 2012